Sprouty1 haploinsufficiency accelerates pheochromocytoma development in Pten+/− mice

Marta Vaquero(Instituto de Investigación Biomédica de Lleida), Mario Encinas(Instituto de Investigación Biomédica de Lleida), Ana Velasco(Instituto de Investigación Biomédica de Lleida), Xavier Matías‐Guiu(Universitat de Lleida), Joan Ribera(Universitat de Lleida), Carlos Anerillas(Centro de Biología Molecular Severo Ochoa), Anna Macià(Instituto de Investigación Biomédica de Lleida)
Endocrine Related Cancer
February 2, 2016
10.1530/erc-15-0585
Cited by 5

Related Papers

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
<scp>FIGO</scp> staging of endometrial cancer: 2023
|International Journal of Gynecology & Obstetrics|2023|926
ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer
|Annals of Oncology|2020|478
Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
|The Journal of Pathology|2019|401
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
|Annals of Oncology|2024|277